(19)
(11) EP 3 313 427 A2

(12)

(88) Date of publication A3:
02.03.2017

(43) Date of publication:
02.05.2018 Bulletin 2018/18

(21) Application number: 16815459.9

(22) Date of filing: 24.06.2016
(51) International Patent Classification (IPC): 
A61K 38/16(2006.01)
A61K 38/03(2006.01)
A61K 49/14(2006.01)
(86) International application number:
PCT/US2016/039431
(87) International publication number:
WO 2016/210376 (29.12.2016 Gazette 2016/52)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
MA MD

(30) Priority: 26.06.2015 US 201562185527 P
26.06.2015 US 201562185529 P
09.10.2015 US 201562239743 P
09.10.2015 US 201562239739 P
14.04.2016 US 201662322724 P

(71) Applicant: Fred Hutchinson Cancer Research Center
Seattle, WA 98109 (US)

(72) Inventors:
  • OLSON, James
    Seattle, WA 98199 (US)
  • STRAND, Andrew, David
    Seattle, WA 98106 (US)
  • GIRARD, Emily, June
    Renton, WA 98058 (US)
  • STRONG, Roland
    Seattle, WA 98103 (US)
  • MEHLIN, Christopher
    Seattle, WA 98107 (US)
  • CORRENTI, Colin
    Seattle, WA 98105 (US)
  • MHYRE, Andrew, James
    Kenmore, WA 98028 (US)
  • BRUSNIAK, Mi-youn
    Lynnwood, WA 98036 (US)
  • SOTTERO, Theo
    Seattle, WA 98133 (US)

(74) Representative: Hobson, David James 
Mathys & Squire LLP The Shard 32 London Bridge Street
London SE1 9SG
London SE1 9SG (GB)

   


(54) THERAPEUTIC PEPTIDES AND METHODS OF USE THEREOF